Louise Frederika Kooij New Amsterdam Pharma CO N.V. (NAMS) insider trading activity

Shares Held (Direct Ownership) 15K

35.54% 3M change

Infinity% 12M change

Total Value Held N/A

Louise Frederika Kooij Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 09 2025	SELL Open market or private sale	$3,856,500 $25.71 p/Share	150,000 Reduced 90.91%	15,000 Ordinary Shares
Sep 09 2025	BUY Exercise of conversion of derivative security	$1,500,000 $10.0 p/Share	150,000 Added 47.62%	165,000 Ordinary Shares
Sep 03 2025	SELL Open market or private sale	$453,451 $25.09 p/Share	18,073 Reduced 54.65%	15,000 Ordinary Shares
Sep 02 2025	BUY Exercise of conversion of derivative security	-	18,073 Added 35.34%	33,073 Ordinary Shares
Aug 25 2025	SELL Open market or private sale	$205,567 $24.86 p/Share	8,269 Reduced 35.54%	15,000 Ordinary Shares
Mar 26 2025	BUY Exercise of conversion of derivative security	-	8,269 Added 26.22%	23,269 Ordinary Shares
Mar 04 2025	SELL Open market or private sale	$3,055,500 $20.37 p/Share	150,000 Reduced 90.91%	15,000 Ordinary Shares
Mar 04 2025	BUY Exercise of conversion of derivative security	-	150,000 Added 47.62%	165,000 Ordinary Shares
Jan 07 2025	BUY Grant, award, or other acquisition	-	15,000 Added 50.0%	15,000 Ordinary Shares
Oct 01 2024	SELL Open market or private sale	$707,400 $15.72 p/Share	45,000 Reduced 100.0%	0 Ordinary Shares
Sep 27 2024	BUY Exercise of conversion of derivative security	-	45,000 Added 50.0%	45,000 Ordinary Shares

LFK

Chief Accounting Officer

Naarden, P7

Receive a notification when an Institution or Guru buys or sells NAMS shares.

Notify only if

Value

Get notified when an New Amsterdam Pharma CO N.V. insider buys or sells NAMS shares.

Notify only if

Operation

Value

Type

Receive news related to NewAmsterdam Pharma Co N.V.